Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Central Nervous System Tumors
20%
Clinical Features
20%
Common Differentially Expressed Genes
20%
Differentially Expressed Genes
40%
Gene Expression Data
20%
Gene Panel
20%
Gene Signature
100%
Glioblastoma multiforme
60%
High-risk Population
20%
Improved Survival
20%
Insulin-like Growth Factor 2 mRNA-binding Protein 2 (IGF2BP2)
20%
Least Absolute Shrinkage and Selection Operator (LASSO)
20%
Low-risk Group
20%
Median Survival
20%
Meta-analysis Approach
20%
Microarray Analysis
20%
Microarray Data
20%
Molecular Biomarkers
20%
Multivariate Analysis
20%
Multivariate Cox Regression
20%
Pathological Features
20%
Poor Prognosis
20%
Poor Survival
20%
Predictive Value
20%
Primary Glioblastoma
100%
Primary Glioblastoma multiforme
60%
Prognostic Biomarker
20%
PTPRN
20%
Risk Score Model
20%
RNA-seq Datasets
20%
SLC39A10
20%
STEAP2
20%
Survival Prediction
100%
Treatment Strategy
20%
Biochemistry, Genetics and Molecular Biology
Gene Expression Data
25%
Gene Signature
100%
High Risk Population
25%
IGFBP2
25%
Low Risk Population
25%
Microarrays
25%
Multivariate Analysis
25%
RNA Sequencing
25%
Survival Prediction
100%
Neuroscience
Central Nervous System
16%
Gene Expression
16%
Glioblastoma Multiforme
100%
Meta-Analysis
33%
Microarrays
16%
RNA-Seq
16%